Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Rexford Industrial Realty
REXR
$8.39B
| $8.82M | 0.01% |
299,432
-207,248
| -41% | -$6.56M |
|
|
UFS
1202
DELISTED
DOMTAR CORPORATION (New)
UFS
| $8.82M | 0.01% |
251,044
-1,497,177
| -86% | -$65.6M |
|
1203
National Beverage
FIZZ
$3.12B
| $8.81M | 0.01% |
+245,474
| New | +$11.3M |
|
1204
General Mills
GIS
$21.3B
| $8.77M | 0.01% |
225,099
+167,054
| +288% | +$7.06M |
|
1205
Houlihan Lokey
HLI
$9.02B
| $8.77M | 0.01% |
238,173
-809,784
| -77% | -$33M |
|
1206
CALL
Pfizer
PFE
$163B
| $8.73M | 0.01% |
+210,800
| New | +$8.75M |
|
|
UNVR
1207
DELISTED
Univar Solutions Inc.
UNVR
| $8.72M | 0.01% |
491,623
-210,364
| -30% | -$4.87M |
|
1208
WEX
WEX
$6.81B
| $8.72M | 0.01% |
+62,250
| New | +$10.2M |
|
1209
McGrath RentCorp
MGRC
$2.8B
| $8.71M | 0.01% |
169,287
+40,495
| +31% | +$2.08M |
|
1210
Teva Pharmaceuticals
TEVA
$44.4B
| $8.69M | 0.01% |
563,719
-210,542
| -27% | -$4.32M |
|
1211
Prosperity Bancshares
PB
$8.72B
| $8.66M | 0.01% |
139,046
+90,861
| +189% | +$5.99M |
|
1212
First Bancorp
FBNC
$2.65B
| $8.63M | 0.01% |
264,211
-5,801
| -2% | -$217K |
|
|
DNR
1213
DELISTED
Denbury Resources, Inc.
DNR
| $8.62M | 0.01% |
5,039,979
+1,184,341
| +31% | +$4.07M |
|
1214
Coherent
COHR
$56.4B
| $8.58M | 0.01% |
+264,326
| New | +$9.86M |
|
1215
Mattel
MAT
$4.36B
| $8.57M | 0.01% |
857,501
+546,792
| +176% | +$7.24M |
|
1216
Provident Financial Services
PFS
$3.06B
| $8.54M | 0.01% |
353,992
+49,344
| +16% | +$1.19M |
|
|
WLL
1217
DELISTED
Whiting Petroleum Corporation
WLL
| $8.51M | 0.01% |
5,003
-2,811
| -36% | -$7.22M |
|
|
CALY
1218
Callaway Golf Company
CALY
$2.76B
| $8.51M | 0.01% |
556,288
-821,921
| -60% | -$16.4M |
|
1219
O-I Glass
OI
$1.15B
| $8.51M | 0.01% |
493,702
-686,950
| -58% | -$12M |
|
1220
Kohl's
KSS
$2B
| $8.5M | 0.01% |
128,175
-539,005
| -81% | -$37.8M |
|
1221
Qualys
QLYS
$6.09B
| $8.5M | 0.01% |
113,761
+23,768
| +26% | +$1.79M |
|
1222
Installed Building Products
IBP
$6.56B
| $8.5M | 0.01% |
252,188
+99,677
| +65% | +$3.46M |
|
1223
Labcorp
LH
$27.4B
| $8.46M | 0.01% |
77,962
+58,335
| +297% | +$7.81M |
|
1224
Minerva Neurosciences
NERV
$239M
| $8.44M | 0.01% |
156,460
+8,732
| +6% | +$639K |
|
|
ERUS
1225
DELISTED
iShares MSCI Russia ETF
ERUS
| $8.44M | 0.01% |
273,900
+37,221
| +16% | +$1.24M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.